Posts tagged CEO at Great Ormond Street Hospital
ViroCell Biologics and Great Ormond Street Hospital for Children Announce Partnership to Dislodge Gene and Cell Therapy “Logjam”
Press ReleasesFlorence BuchananCDMO, UK CDMO, ViroCell, ViroCell Biologics, Great Ormond Street Hospital for Children, GOSH, NHS Foundation Trust, lentivirus vector, AAV vectors, cell and gene therapies, gene therapy, cell therapy, Zayed Centre for Research, 1L to 200L batch size, Scientific Advisory Board, John W. Hadden II, Matthew Shaw, CEO at Great Ormond Street Hospital, Great Ormond Street Hospital, Her Highness Sheikha Fatima bint Mubarak, Sheikh Zayed bin Sultan Al Nahyan, Founder of the United Arab Emirates, rare diseases, Great Ormond Street Hospital Children’s Charity, EQ, James Culverhouse, ViroCell Press Release
